| Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA MA Coelho, S de Carné Trécesson, S Rana, D Zecchin, C Moore, ... Immunity 47 (6), 1083-1099. e6, 2017 | 536 | 2017 |
| The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition S Courapied, H Sellier, S de Carné Trécesson, A Vigneron, AC Bernard, ... Journal of Biological Chemistry 285 (35), 26765-26778, 2010 | 95 | 2010 |
| Antibodies against endogenous retroviruses promote lung cancer immunotherapy KW Ng, J Boumelha, KSS Enfield, J Almagro, H Cha, O Pich, T Karasaki, ... Nature 616 (7957), 563-573, 2023 | 90 | 2023 |
| Tight sequestration of BH3 proteins by BCL-xL at subcellular membranes contributes to apoptotic resistance J Pécot, L Maillet, J Le Pen, C Vuillier, S de Carné Trécesson, A Fétiveau, ... Cell reports 17 (12), 3347-3358, 2016 | 65 | 2016 |
| Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells A Basseville, L Preisser, S de Carné Trécesson, M Boisdron-Celle, ... Molecular cancer 10, 1-12, 2011 | 61 | 2011 |
| Genomic–transcriptomic evolution in lung cancer and metastasis C Martínez-Ruiz, JRM Black, C Puttick, MS Hill, J Demeulemeester, ... Nature 616 (7957), 543-552, 2023 | 60 | 2023 |
| Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins S de Carné Trécesson, Y Guillemin, A Bélanger, AC Bernard, L Preisser, ... Journal of Biological Chemistry 286 (15), 12825-12838, 2011 | 55 | 2011 |
| Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1 B Jonchère, A Vétillard, B Toutain, D Lam, AC Bernard, C Henry, ... Oncotarget 6 (1), 409, 2015 | 47 | 2015 |
| BCL-XL directly modulates RAS signalling to favour cancer cell stemness S Carné Trécesson, F Souazé, A Basseville, AC Bernard, J Pécot, ... Nature Communications 8 (1), 1123, 2017 | 45 | 2017 |
| Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival F Braun, S de Carné Trécesson, J Bertin-Ciftci, P Juin Cell Cycle 12 (18), 2937-2947, 2013 | 41 | 2013 |
| An immunogenic model of KRAS-mutant lung cancer enables evaluation of targeted therapy and immunotherapy combinations J Boumelha, S de Carné Trécesson, EK Law, P Romero-Clavijo, ... Cancer research 82 (19), 3435-3448, 2022 | 38* | 2022 |
| Carcinoma-associated fucosylated antigens are markers of the epithelial state and can contribute to cell adhesion through CLEC17A (Prolectin) A Breiman, MDL Robles, S de Carné Trécesson, K Echasserieau, ... Oncotarget 7 (12), 14064, 2016 | 23 | 2016 |
| RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma P East, GP Kelly, D Biswas, M Marani, DC Hancock, T Creasy, ... Nature communications 13 (1), 5632, 2022 | 20 | 2022 |
| The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance DR Caswell, P Gui, MK Mayekar, EK Law, O Pich, C Bailey, J Boumelha, ... Nature Genetics 56 (1), 60-73, 2024 | 19 | 2024 |
| Combining RASG12C(ON) inhibitor with SHP2 inhibition sensitises immune excluded lung tumours to immune checkpoint blockade: a strategy for turning cold … P Anastasiou, C Moore, S Rana, A de Castro, M Tomaschko, J Boumelha, ... bioRxiv, 2024.01. 15.575765, 2024 | 1 | 2024 |
| In vivo CRISPR screen identifies KRAS-induced COX-2 as a driver of immune evasion and immunotherapy resistance in lung cancer J Boumelha, A de Castro, N Bah, H Cha, S de Carné Trécesson, S Rana, ... bioRxiv, 2023.04. 13.536740, 2023 | 1 | 2023 |
| Oncogène RAS et Cancer Colorectal: Étude de la Réponse au Stress Oncogénique et de l'Échappement à la Sénescence S de Carné Trécesson Université d'Angers, 2010 | 1 | 2010 |
| RAS orchestrates an increase of interstitial adenosine in lung adenocarcinoma to promote immune evasion S de Carné Trécesson, J Boumhela, C Moore, D Caswell, ... European Journal of Cancer 138, S20-S21, 2020 | | 2020 |
Julian DownwardFrancis Crick Institute在 crick.ac.uk 的电子邮件经过验证
